Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar pchop123 (79.86) Submitted: 10/15/2012 10:13:34 AM : Outperform Start Price: $22.37 CLSN Score: -6.78

green thumb after a little dip

Featured Broker Partners


Advertisement